Challenging CDKN2A assessment in BRAF-altered gliomas: lessons from a pleomorphic xanthoastrocytoma-enriched cohort. - Wolf T; Reita D; Deschuyter M; Salmanli C; Buffa J; Pencreach E; Guérin E; Jeandidier E; Miguet M; Chenard MP; Geyer L; Noel G; et al. (Acta neuropathologica communications, 2025)